Original Source(s)
Related Content
Merck Highlights Early Tiespectus Data
At the ASRS meeting in Montreal, Baruch D. Kuppermann, MD, PhD, presented BRVO findings from the phase 1/2a RIOJA program evaluating the investigational VEGF/Tie2 bispecific.
July 15, 2026
-
3 min